Skip to content
10-Q

Quarterly Report

LAVA MEDTECH ACQUISITION CORP.

0001213900-22-027078

← back to feed
Filed
May 16, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$207.47K
Cash And Equivalents Q1 2022 · Mar 31, 2022 $1.33M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $1.54M
Stockholders Equity Q1 2022 · Mar 31, 2022 −$5.35M
Stockholders Equity Q1 2022 · Dec 31, 2021 −$6.47M
Current Liabilities Q1 2022 · Mar 31, 2022 $234.28K
Current Liabilities Q1 2022 · Dec 31, 2021 $120.23K
Total Liabilities Q1 2022 · Mar 31, 2022 $7.47M
Total Liabilities Q1 2022 · Dec 31, 2021 $8.9M
Current Assets Q1 2022 · Mar 31, 2022 $1.87M
Current Assets Q1 2022 · Dec 31, 2021 $2.2M
Total Assets Q1 2022 · Mar 31, 2022 $119.99M
Total Assets Q1 2022 · Dec 31, 2021 $120.3M
Sga Expense Q1 2022 · Mar 31, 2022 $400.17K
Sga Expense Q1 2022 · Mar 31, 2021 $1K
Net Income Q1 2022 · Mar 31, 2022 $1.12M
Net Income Q1 2022 · Mar 31, 2021 −$1K